A detailed history of Hillsdale Investment Management Inc. transactions in Vericel Corp stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 119,689 shares of VCEL stock, worth $5.59 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
119,689
Previous 110,389 8.42%
Holding current value
$5.59 Million
Previous $3.93 Million 58.42%
% of portfolio
0.55%
Previous 0.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $302,436 - $486,669
9,300 Added 8.42%
119,689 $6.23 Million
Q4 2023

Feb 09, 2024

BUY
$30.85 - $37.09 $2.59 Million - $3.12 Million
84,100 Added 319.91%
110,389 $3.93 Million
Q3 2023

Nov 09, 2023

BUY
$31.69 - $39.25 $833,098 - $1.03 Million
26,289 New
26,289 $881,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.2B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.